Feature

POWER MORCELLATION and the Risk of Uterine Sarcoma Dissemination

Aug 15th, 2014 | By
POWER MORCELLATION and the Risk of Uterine Sarcoma Dissemination

By Dan Bolton, Keller, Fishback & Jackson LLP., Sponsored Content An estimated 50,000 women a year in the United States undergo a hysterectomy (removal of the uterus) or myomectomy (removal of uterine fibroids) with the use of a medical device known as a power morcellator. Power morcellators typically use a rapidly rotating blade to cut
[continue reading...]



LEGAL THOUGHTS ON THE AMS TRANSVAGINAL MESH SETTLEMENT

May 22nd, 2014 | By
LEGAL THOUGHTS ON THE AMS TRANSVAGINAL MESH SETTLEMENT

SPONSORED CONTENT By Dan C. Bolton, Of Counsel, Keller, Fishback & Jackson LLP                 Recently, Endo Pharmaceuticals announced that it had reached a settlement in principle with four law firms representing plaintiffs in the transvaginal mesh litigation pending before Judge Goodwin in federal district court in West Virginia (MDL 2325).  The Press Release issued by
[continue reading...]



Hernia Mesh Lawsuit Filed Against Atrium Medical Corporation

Mar 11th, 2014 | By
Hernia Mesh Lawsuit Filed Against Atrium Medical Corporation

Hernia Mesh Lawsuit Filed Against Atrium Medical Corporation By Dan C. Bolton and Farid Zakaria, Keller, Fishback & Jackson LLP The law firm of Keller, Fishback & Jackson LLP recently filed a lawsuit in California federal court on behalf of a forty-six year old man injured by a hernia mesh product. The lawsuit alleges claims
[continue reading...]



The 510(k) Process – Safety Forgotten

Jan 23rd, 2014 | By
The 510(k) Process – Safety Forgotten

Sponsored Content THE 510(k) PROCESS – SAFETY FORGOTTEN By Dan C. Bolton, Of Counsel, Keller, Fishback & Jackson LLP The 510(k) process is relied upon by the medical device industry, including pelvic mesh manufacturers, such as Ethicon/Johnson & Johnson, Atrium Medical Corporation, and Davol/Bard, to quickly get devices marketed in the United States.  (The term
[continue reading...]



J&J Systematically Destroyed Evidence in Upcoming Mesh Trials, Pl Lawyers Call it ”Severe” Destruction of Evidence

Dec 8th, 2013 | By
J&J Systematically Destroyed Evidence in Upcoming Mesh Trials, Pl Lawyers Call it ”Severe” Destruction of Evidence

Ethicon Pelvic Repair System Products Liability Litigation, 12-MD-02327, In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation Joseph R. Goodwin, presiding Date filed: 02/07/2012 Date of last filing: 12/03/2013 PART ONE     (Continues in Part 2) According to a 30-page document filed in federal court in West Virginia December 2, officials at Johnson & Johnson
[continue reading...]



What was Lost in J&J Purge of Ethicon Transvaginal Mesh Documents?

Dec 8th, 2013 | By
What was Lost in J&J Purge of Ethicon Transvaginal Mesh Documents?

PART  TWO    (Continued from Part I here) Lawyers for thousands of women who have filed product liability lawsuits against Johnson & Johnson and its  Ethicon division say the company purged documents for a decade, documents that are crucial to proving their defective transvaginal mesh cases in federal court. Calling it a “systemic failure at all
[continue reading...]



SUBROGATION & MESH– What it means and why you must understand it

Oct 30th, 2013 | By
SUBROGATION & MESH– What it means and why you must understand it

By Aaron Leigh Horton According Dr. Shlomo Raz at UCLA, the leading expert for 100% removal of transvaginal mesh from the body, “I think that more than 1 million patients [have polypropylene mesh implanted]! The companies have reported insertion of 250,000 implants per year!  This number is an estimate of the worldwide use of mesh.”
[continue reading...]



Court Schedule for Bellwether Trials Posted in Upcoming Transvaginal Mesh Cases

Oct 14th, 2013 | By
Court Schedule for Bellwether Trials Posted in Upcoming Transvaginal Mesh Cases

The federal court in Charleston, West Virginia, that has more than 33,000 defective product claims consolidated in something called Multidistrict Litigation (MDL), now has a new section on the website for each MDL bellwether trial. Each of six transvaginal mesh manufacturers will face off with plaintiffs in four jury trials intended to test legal theories
[continue reading...]



Tolling Agreements – Legal Deadlines Nearing for Mesh-Injured

Sep 15th, 2013 | By

by Aaron Leigh Horton Blog:   @themeshwarrior.wordpress.com Twitter:  @themeshwarrior Email:  themeshwarrior@gmail.com September 12, 2013 – According to USDefinitions.legal.com, a tolling agreement is an agreement to waive a right to claim that litigation should be dismissed due to the expiration of a statute of limitations. Its purpose is typically to allow a party additional time to assess
[continue reading...]



Law Professor Thomas A. Eaton on Tort Reform

Aug 29th, 2013 | By
Law Professor Thomas A. Eaton on Tort Reform

Earlier this month, the jury in the federal Donna Cisson transvaginal mesh case awarded Mrs. Cisson $1.75 million in punitive damages in addition to the $250,000 in compensatory damages. The Cisson case established the Bard Avaulta mesh she received as a treatment for pelvic organ prolapse was defective. Yet readers learned something startling about any
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.